Advanced Enzymes Q1 net profit fell 7.5% to ₹37 crore, revenue rose 2.2% to ₹190 crore.
EBITDA declined 9.6% to ₹51.1 crore, with margins dropping to 26.9%.
The company approved a ₹697 million share buyback and acquired 4.28% of JC Biotech stake.
Shares closed 1.79% lower at ₹323.90, despite 11.08% rise in past 6 months.








